Background illustration for clinical trials search

Paid Clinical Trials Waterbury

Discover 1,141 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,141

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

for

Overweight, Obesity

Location: Waterbury CT, New Haven CT, Bridgeport CT, New York NY,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07392190

Phase3, Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for

Acute Migraine

Location: Waterbury CT, Commack NY, New York NY, Brooklyn NY,

Sponsor: Kallyope Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase3, Recruiting

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for

Cardiovascular Disease and Lipoprotein(a)

Location: Waterbury CT, Hartford CT, Bridgeport CT, Riverhead NY,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07517263

Phase3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: Waterbury CT, The Bronx NY, Laurelton NY, New York NY,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for

Heart Failure

Location: Waterbury CT, Bridgeport CT, Stamford CT, Massapequa NY,

Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase3, Recruiting

New

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

for

Influenza, Human

Location: Waterbury CT, Stamford CT, Hartsdale NY,

Sponsor: GlaxoSmithKline

Sex: All

Age: 65+

Code: NCT07805707

Phase3, Recruiting

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

for

Advanced Extrapulmonary Neuroendocrine Carcinoma,

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05058651

Phase2, Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for

Breast Cancer

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07062965

Phase3, Recruiting

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

for

Sinonasal Squamous Cell Carcinoma,

Location: Waterbury CT, New Haven CT, Trumbull CT, Waterford CT,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07281417

Phase2, Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for

Gastric Adenocarcinoma,

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT07001748

Phase2, Phase3, Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for

Advanced Hepatocellular Carcinoma,

Location: Waterbury CT, Hamden CT, North Haven CT, Derby CT,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase3, Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for

Anatomic Stage I Breast Cancer AJCC v8,

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase3, Recruiting

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

for

Extensive Stage Lung Small Cell Carcinoma,

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06769126

Phase2, Recruiting

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

for

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma,

Location: Waterbury CT, Hamden CT, North Haven CT, Derby CT,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06958328

Phase3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for

Muscle Invasive Bladder Urothelial Carcinoma,

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase2, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for

Pancreatic Neoplasm

Location: Waterbury CT, Hamden CT, North Haven CT, Derby CT,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase3, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for

Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase2, Recruiting

ATEMPT 2.0: Adjuvant T-DM1 vs TH

for

Breast Cancer, HER2-positive Breast Cancer

Location: Waterbury CT, North Haven CT, Derby CT, New Haven CT,

Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04893109

Phase2, Recruiting

Paid Clinical Trials Waterbury

Filter results

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Interested in new trials?

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

ATEMPT 2.0: Adjuvant T-DM1 vs TH